ascorbic-acid has been researched along with lenvatinib* in 1 studies
1 other study(ies) available for ascorbic-acid and lenvatinib
| Article | Year |
|---|---|
Combination of Vitamin C and Lenvatinib potentiates antitumor effects in hepatocellular carcinoma cells
Lenvatinib has become a first-line drug in the treatment of advanced hepatocellular carcinoma (HCC). Investigating its use in combination with other agents is of great significance to improve the sensitivity and durable response of Lenvatinib in advanced HCC patients. Vitamin C (L-ascorbic acid, ascorbate, VC) is an important natural antioxidant, which has been reported to show suppressive effects in cancer treatment. Here, we investigated the effect of the combination of VC and Lenvatinib in HCC cells Topics: Antineoplastic Agents; Ascorbic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms | 2023 |